85 related articles for article (PubMed ID: 12502438)
1. [Antitumor immunity elicited by 4-1BBL gene transfected Hepa1-6 in vivo].
Li X; Li X; Huang J; Wei L; Chen L; Wu M; Guo Y
Zhonghua Gan Zang Bing Za Zhi; 2002 Dec; 10(6):409-12. PubMed ID: 12502438
[TBL] [Abstract][Full Text] [Related]
2. [Antitumor immune responses induced by gene transfer of 4-1BBL into hepatocellular carcinoma Hepa1-6 in vitro].
Liu CL; Dou KF; Zang XX; Zhu BF; Chen SM
Zhonghua Wai Ke Za Zhi; 2004 May; 42(9):554-8. PubMed ID: 15196371
[TBL] [Abstract][Full Text] [Related]
3. [Cloning, expression and antitumor effect of mouse costimulatory molecule 4-1BBL].
Liu CL; Dou KF; Zhu BF; Zang XX; Chai YB; Du KJ; Chen SM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Jan; 20(1):118-22. PubMed ID: 15182637
[TBL] [Abstract][Full Text] [Related]
4. [Immunological killing effect of recombicant adenovirus vector rAD-mTERT-m4-1BBL on mouse hepatoma cell line Hepa1-6 cells co-cultured with T lymphocytes].
Xiao ZS; Ma SY; Gong WD; Yao HH; DU P; Xing YQ; Wu HR
Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):894-8. PubMed ID: 20193326
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of antitumor activity of CD40L, RANKL, and 4-1BBL in vivo following intratumoral administration of viral vectors or transduced dendritic cells.
Yurkovetsky ZR; Shurin GV; Barry DA; Schuh AC; Shurin MR; Robbins PD
J Gene Med; 2006 Feb; 8(2):129-37. PubMed ID: 16288496
[TBL] [Abstract][Full Text] [Related]
6. Growth suppression of the hepatocellular carcinoma cell line Hepa1-6 by an activatable interferon regulatory factor-1 in mice.
Kröger A; Ortmann D; Krohne TU; Mohr L; Blum HE; Hauser H; Geissler M
Cancer Res; 2001 Mar; 61(6):2609-17. PubMed ID: 11289138
[TBL] [Abstract][Full Text] [Related]
7. [Construction of PCI-neo mammalian expression vector system containing murine 4-1BBL gene and its stable expression in hepatocellular carcinoma cell line].
Li GQ; Wang XH; Yin J; Yu Y
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):328-31. PubMed ID: 12921558
[TBL] [Abstract][Full Text] [Related]
8. The systemic administration of Ig-4-1BB ligand in combination with IL-12 gene transfer eradicates hepatic colon carcinoma.
Xu DP; Sauter BV; Huang TG; Meseck M; Woo SL; Chen SH
Gene Ther; 2005 Oct; 12(20):1526-33. PubMed ID: 15973445
[TBL] [Abstract][Full Text] [Related]
9. Adoptively transferred tumor-specific T cells stimulated ex vivo using herpes simplex virus amplicons encoding 4-1BBL persist in the host and show antitumor activity in vivo.
Yi KH; Nechushtan H; Bowers WJ; Walker GR; Zhang Y; Pham DG; Podack ER; Federoff HJ; Tolba KA; Rosenblatt JD
Cancer Res; 2007 Oct; 67(20):10027-37. PubMed ID: 17942937
[TBL] [Abstract][Full Text] [Related]
10. [Prostate cancer cell vaccine transfected with 4-1BBL induces anti-tumor immunity in vitro].
Kuang YL; Weng XD; Liu XH; Chen ZY; Zhu HC; Jiang BT
Zhonghua Nan Ke Xue; 2010 Sep; 16(9):773-7. PubMed ID: 21171257
[TBL] [Abstract][Full Text] [Related]
11. Autologous tumor vaccine lowering postsurgical recurrent rate of hepatocellular carcinoma.
Peng B; Liang L; Chen Z; He Q; Kuang M; Zhou F; Lu M; Huang J
Hepatogastroenterology; 2006; 53(69):409-14. PubMed ID: 16795983
[TBL] [Abstract][Full Text] [Related]
12. [Inhibitory effect of 4-1BBL combined with Hsp70-tumor antigen peptides on pulmonary metastasis of melanoma in mice].
Qiu H; Zhang GM; Zhang H; Yuan Y; Li D; Feng ZH
Ai Zheng; 2005 Jul; 24(7):781-6. PubMed ID: 16004800
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic effects of simultaneous expression of 4-1BBL and sPD-1 on experimental murine hepatoma].
Qiu H; Zhang H; Feng ZH; Geng H; Zhang GM
Zhonghua Gan Zang Bing Za Zhi; 2006 Jul; 14(7):505-9. PubMed ID: 16867271
[TBL] [Abstract][Full Text] [Related]
14. Soluble PD-1 facilitates 4-1BBL-triggered antitumor immunity against murine H22 hepatocarcinoma in vivo.
Xiao H; Huang B; Yuan Y; Li D; Han LF; Liu Y; Gong W; Wu FH; Zhang GM; Feng ZH
Clin Cancer Res; 2007 Mar; 13(6):1823-30. PubMed ID: 17325342
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effects of interleukin-18 gene-modified hepatocyte cell line on implanted liver carcinoma.
Leng J; Zhang L; Yao H; Cao X
Chin Med J (Engl); 2003 Oct; 116(10):1475-9. PubMed ID: 14570604
[TBL] [Abstract][Full Text] [Related]
16. [The in vivo antitumor activity of murine liver tumor vaccine expressing MIP-1alpha].
Yang Q; Yang G; Wei L; Jia F; Wang W; Wu M; Guo Y
Zhonghua Wai Ke Za Zhi; 2002 Oct; 40(10):789-91. PubMed ID: 12487888
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic T cell immunity against the non-immunogenic, murine, hepatocellular carcinoma Hepa1-6 is directed towards the novel alternative form of macrophage colony stimulating factor.
Ge L; Zhang JG; Samathanam CA; Delgado C; Tarbiyat-Boldaji M; Dan Q; Hoa N; Nguyen TV; Alipanah R; Pham JT; Sanchez R; Wepsic HT; Morgan TR; Jadus MR
Cell Immunol; 2009; 259(2):117-27. PubMed ID: 19615673
[TBL] [Abstract][Full Text] [Related]
18. Immuno-gene therapy with adenoviruses expressing fms-like tyrosine kinase 3 ligand and CD40 ligand for mouse hepatoma cells in vivo.
Yanagi K; Nagayama Y; Nakao K; Saeki A; Matsumoto K; Ichikawa T; Ishikawa H; Hamasaki K; Ishii N; Eguchi K
Int J Oncol; 2003 Feb; 22(2):345-51. PubMed ID: 12527933
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory gene therapy with interleukin 12 and 4-1BB ligand: long- term remission of liver metastases in a mouse model.
Martinet O; Ermekova V; Qiao JQ; Sauter B; Mandeli J; Chen L; Chen SH
J Natl Cancer Inst; 2000 Jun; 92(11):931-6. PubMed ID: 10841829
[TBL] [Abstract][Full Text] [Related]
20. Combined alpha tumor necrosis factor gene therapy and engineered dendritic cell vaccine in combating well-established tumors.
Liu Y; Saxena A; Zheng C; Carlsen S; Xiang J
J Gene Med; 2004 Aug; 6(8):857-68. PubMed ID: 15293344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
